Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 85101 - 85125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Troglitazone	Approved Withdrawn	MT2A	4502	upregulated	troglitazone results in increased expression of MT2A mRNA	16q13	A24107
Troglitazone	Approved Withdrawn	MUC13	56667	upregulated	troglitazone results in increased expression of MUC13 mRNA	3q21.2	A22609
Troglitazone	Approved Withdrawn	MUC2	4583	upregulated	troglitazone results in increased expression of MUC2 mRNA	11p15.5	A24662
Troglitazone	Approved Withdrawn	MVK	4598	downregulated	troglitazone results in decreased expression of MVK mRNA	12q24.11	A22609
Troglitazone	Approved Withdrawn	MVP	9961	upregulated	troglitazone results in increased expression of MVP mRNA	16p11.2	A24633
Troglitazone	Approved Withdrawn	MXD3	83463	downregulated	troglitazone results in decreased expression of MXD3 mRNA	5q35.3	A24633
Troglitazone	Approved Withdrawn	MXD4	10608	upregulated	troglitazone results in increased expression of MXD4 mRNA	4p16.3	A24633
Troglitazone	Approved Withdrawn	MXRA5	25878	downregulated	troglitazone results in decreased expression of MXRA5 mRNA	Xp22.33	A24633
Troglitazone	Approved Withdrawn	MYB	4602	downregulated	troglitazone results in decreased expression of MYB mRNA	6q23.3	A21664
Troglitazone	Approved Withdrawn	MYBL2	4605	downregulated	troglitazone results in decreased expression of MYBL2 mRNA	20q13.12	A24658
Troglitazone	Approved Withdrawn	MYC	4609	downregulated	troglitazone results in decreased expression of MYC mRNA	8q24.21	A21664 A24663 A24664
Troglitazone	Approved Withdrawn	MYC	4609	upregulated	troglitazone results in increased expression of MYC mRNA	8q24.21	A24107
Troglitazone	Approved Withdrawn	MYO10	4651	upregulated	troglitazone results in increased expression of MYO10 mRNA	5p15.1	A24633
Troglitazone	Approved Withdrawn	NAMPT	10135	upregulated	troglitazone results in increased expression of NAMPT mRNA	7q22.3	A24633
Troglitazone	Approved Withdrawn	NASP	4678	downregulated	troglitazone results in decreased expression of NASP mRNA	1p34.1	A24633
Troglitazone	Approved Withdrawn	NAT16	375607	downregulated	troglitazone results in decreased expression of NAT16 mRNA	7q22.1	A22609
Troglitazone	Approved Withdrawn	NAV1	89796	upregulated	troglitazone results in increased expression of NAV1 mRNA	1q32.1	A24633
Troglitazone	Approved Withdrawn	NCAPG	64151	downregulated	troglitazone results in decreased expression of NCAPG mRNA	4p15.31	A24633
Troglitazone	Approved Withdrawn	NDRG1	10397	upregulated	troglitazone results in increased expression of NDRG1 mRNA	8q24.22	A24633
Troglitazone	Approved Withdrawn	NEIL3	55247	downregulated	troglitazone results in decreased expression of NEIL3 mRNA	4q34.3	A24633
Troglitazone	Approved Withdrawn	NEK2	4751	downregulated	troglitazone results in decreased expression of NEK2 mRNA	1q32.3	A24633
Troglitazone	Approved Withdrawn	NFIL3	4783	upregulated	troglitazone results in increased expression of NFIL3 mRNA	9q22.31	A24633
Troglitazone	Approved Withdrawn	NFKBIA	4792	upregulated	troglitazone results in increased expression of NFKBIA mRNA	14q13.2	A24107
Troglitazone	Approved Withdrawn	NID2	22795	upregulated	troglitazone results in increased expression of NID2 mRNA	14q22.1	A24633
Troglitazone	Approved Withdrawn	NOS2	4843	upregulated	troglitazone results in increased expression of NOS2 mRNA	17q11.2	A24107

Displaying entries 85101 - 85125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability